Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,500 | |||
25 mg | 在庫あり | ¥ 19,000 | |||
50 mg | 在庫あり | ¥ 34,000 | |||
100 mg | 在庫あり | ¥ 57,500 | |||
200 mg | 在庫あり | ¥ 82,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury. |
別名 | A4166, Senaglinide |
分子量 | 317.42 |
分子式 | C19H27NO3 |
CAS No. | 105816-04-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (189.02 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nateglinide 105816-04-4 DNA Damage/DNA Repair Membrane transporter/Ion channel Metabolism Proteases/Proteasome Ubiquitination PPAR Potassium Channel Proteasome insulin β-cell DPP inhibit A 4166 A-4166 Inhibitor A4166 KcsA Dipeptidyl Peptidase Senaglinide diabetes short-acting glucose inhibitor